NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, October 4th. Investors of record on Wednesday, October 24th will be paid a dividend of $0.50 per share on Thursday, November 1st. This represents a $2.00 annualized dividend and a dividend yield of 2.66%. The ex-dividend date is Tuesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its quarterly earnings results on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.02. The pharmacy operator had revenue of $47.27 billion for the quarter, compared to analyst estimates of $47.22 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. CVS Health's quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.50 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided earnings per share guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

17 analysts have issued 1 year price objectives for CVS Health's shares. Their predictions range from $76.00 to $100.00. On average, they anticipate CVS Health's stock price to reach $90.9333 in the next year. This suggests a possible upside of 21.1% from the stock's current price. View Analyst Price Targets for CVS Health.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 4 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media stories about CVS stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CVS Health earned a news impact score of 0.7 on InfoTrie's scale. They also assigned news articles about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next few days.

CVS Health saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 58,223,127 shares, an increase of 0.2% from the October 15th total of 58,345,396 shares. Based on an average trading volume of 7,427,896 shares, the days-to-cover ratio is presently 7.8 days. Approximately 5.7% of the company's shares are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.48%), FMR LLC (2.95%), Dodge & Cox (1.48%), Bank of New York Mellon Corp (1.23%), Franklin Resources Inc. (1.15%) and Veritas Asset Management LLP (1.15%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, The Manufacturers Life Insurance Company , Mitsubishi UFJ Trust & Banking Corp, State Treasurer State of Michigan, Swedbank, PGGM Investments, Bridgewater Associates LP and Mackenzie Financial Corp. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, Helena Foulkes, Kevin Hourican, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including Dodge & Cox, Capital International Investors, Diamond Hill Capital Management Inc., BlackRock Inc., Senator Investment Group LP, HealthCor Management L.P., FMR LLC and Point72 Asset Management L.P.. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $75.1050.

CVS Health has a market capitalization of $80.03 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]